Sort   by:  
 Page size 
ModelsDurot2008_A.Baylyi_ADP1Metabolism
This is the constraint based model from: Iterative reconstruction of a global metabolic model of Acinetobacter baylyi ADP1 using high-throughput growth phenotype and gene essentiality d ata. Durot M et al. BMC Syst Biol. 2008; 2: 85.; pubmed ID: 1...
2005-01-01 | MODEL1949107276 | BioModels
UnknownRisk Prediction for Delayed Allograft Function: Analysis of the Deterioration of Kidney Allograft Function (DeKAF) Study Data.
Not available
S-EPMC8380757 | biostudies-literature
UnknownConversion from twice-daily tacrolimus to once-daily extended release tacrolimus (LCPT): the phase III randomized MELT trial.
Not available
S-EPMC3613750 | biostudies-literature
UnknownMutations in FAM111B cause hereditary fibrosing poikiloderma with tendon contracture, myopathy, and pulmonary fibrosis.
Not available
S-EPMC3853004 | biostudies-literature
GenomicsAS
WTCCC2 project samples from Ankylosing spondylitis Cohort
EGAD00010000150 | EGA
GenomicsGenomewide association studies in ankylosing spondylitis
The aim of this study was to identify genes associated with ankylosing spondylitis susceptibility in British and Australian individuals of European descent.
EGAS00000000104 | EGA
UnknownComplement factor H genetic variant and age-related macular degeneration: effect size, modifiers and relationship to disease subtype.
Not available
S-EPMC3304526 | biostudies-literature
UnknownAdjuvant Olaparib for Patients with <i>BRCA1</i>- or <i>BRCA2</i>-Mutated Breast Cancer.
Not available
S-EPMC9126186 | biostudies-literature
UnknownExpanding the clinical spectrum of hereditary fibrosing poikiloderma with tendon contractures, myopathy and pulmonary fibrosis due to FAM111B mutations.
Not available
S-EPMC4608180 | biostudies-literature
UnknownNon-trough adalimumab and certolizumab drug levels associated with a therapeutic EULAR response in adherent patients with rheumatoid arthritis.
Not available
S-EPMC10234202 | biostudies-literature
Sort   by:  
 Page size